This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Dalhousie University, International Vaccines Institute, The University of British Columbia. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 82 
1 out of 1 
1 out of 963 
Years Active: 2015-2016
Title: Mi-Na Kweon: Innovator in Immune Response Formulation
Introduction
Mi-Na Kweon is an accomplished inventor based in Seoul, South Korea, recognized for his significant contributions to the field of immunology. With a total of two patents to his name, Kweon has been instrumental in developing innovative solutions aimed at enhancing immune responses against various microbial infections.
Latest Patents
Kweon's latest patents focus on a combination adjuvant formulation designed to improve immune responses to selected antigens. The described methods and compositions are particularly useful in the treatment and prevention of infections caused by bacteria, viruses, fungi, and parasites. These formulations incorporate host defense peptides, polyphosphazenes, and immunostimulatory sequences, collectively enhancing the immune response to coadministered antigens.
Career Highlights
Mi-Na Kweon's career includes significant tenures at esteemed educational institutions. He has worked at the University of Saskatchewan and Dalhousie University, where he has contributed his expertise in immunology and vaccine development.
Collaborations
Throughout his career, Kweon has collaborated with notable colleagues, including Volker Gerdts and Andrew A. Potter. These partnerships have facilitated the advancement of his research and the successful development of his patented innovations.
Conclusion
In summary, Mi-Na Kweon stands out as a pioneering inventor in the realm of immune response enhancement. His innovative patents and collaborative efforts reflect his commitment to advancing medical science and improving health outcomes through effective microbial infection prevention and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile